Global NK Cells Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 115

Report ID: 348244

The global NK Cells market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the NK Cells market based on company, product type, end user and key regions.

This report studies the global market size of NK Cells in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NK Cells in these regions.
This research report categorizes the global NK Cells market by top players/brands, region, type and end user. This report also studies the global NK Cells market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Market size by Product
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market size by End User
Cancer
Cardiovascular Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global NK Cells market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of NK Cells market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global NK Cells companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of NK Cells submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of NK Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NK Cells market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 NK Cells Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global NK Cells Market Size Growth Rate by Product
1.4.2 Mogamulizumab
1.4.3 Lorvotuzumab Mertansine
1.4.4 Others
1.5 Market by End User
1.5.1 Global NK Cells Market Size Growth Rate by End User
1.5.2 Cancer
1.5.3 Cardiovascular Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global NK Cells Market Size
2.1.1 Global NK Cells Revenue 2014-2025
2.1.2 Global NK Cells Sales 2014-2025
2.2 NK Cells Growth Rate by Regions
2.2.1 Global NK Cells Sales by Regions
2.2.2 Global NK Cells Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 NK Cells Sales by Manufacturers
3.1.1 NK Cells Sales by Manufacturers
3.1.2 NK Cells Sales Market Share by Manufacturers
3.1.3 Global NK Cells Market Concentration Ratio (CR5 and HHI)
3.2 NK Cells Revenue by Manufacturers
3.2.1 NK Cells Revenue by Manufacturers (2014-2019)
3.2.2 NK Cells Revenue Share by Manufacturers (2014-2019)
3.3 NK Cells Price by Manufacturers
3.4 NK Cells Manufacturing Base Distribution, Product Types
3.4.1 NK Cells Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NK Cells Product Type
3.4.3 Date of International Manufacturers Enter into NK Cells Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global NK Cells Sales by Product
4.2 Global NK Cells Revenue by Product
4.3 NK Cells Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global NK Cells Breakdown Data by End User

6 North America
6.1 North America NK Cells by Countries
6.1.1 North America NK Cells Sales by Countries
6.1.2 North America NK Cells Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America NK Cells by Product
6.3 North America NK Cells by End User

7 Europe
7.1 Europe NK Cells by Countries
7.1.1 Europe NK Cells Sales by Countries
7.1.2 Europe NK Cells Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe NK Cells by Product
7.3 Europe NK Cells by End User

8 Asia Pacific
8.1 Asia Pacific NK Cells by Countries
8.1.1 Asia Pacific NK Cells Sales by Countries
8.1.2 Asia Pacific NK Cells Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific NK Cells by Product
8.3 Asia Pacific NK Cells by End User

9 Central & South America
9.1 Central & South America NK Cells by Countries
9.1.1 Central & South America NK Cells Sales by Countries
9.1.2 Central & South America NK Cells Revenue by Countries
9.1.3 Brazil
9.2 Central & South America NK Cells by Product
9.3 Central & South America NK Cells by End User

10 Middle East and Africa
10.1 Middle East and Africa NK Cells by Countries
10.1.1 Middle East and Africa NK Cells Sales by Countries
10.1.2 Middle East and Africa NK Cells Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa NK Cells by Product
10.3 Middle East and Africa NK Cells by End User

11 Company Profiles
11.1 Chipscreen Biosciences (China)
11.1.1 Chipscreen Biosciences (China) Company Details
11.1.2 Company Business Overview
11.1.3 Chipscreen Biosciences (China) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Chipscreen Biosciences (China) NK Cells Products Offered
11.1.5 Chipscreen Biosciences (China) Recent Development
11.2 Affimed NV (Netherlands)
11.2.1 Affimed NV (Netherlands) Company Details
11.2.2 Company Business Overview
11.2.3 Affimed NV (Netherlands) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Affimed NV (Netherlands) NK Cells Products Offered
11.2.5 Affimed NV (Netherlands) Recent Development
11.3 Altor BioScience Corporation (USA)
11.3.1 Altor BioScience Corporation (USA) Company Details
11.3.2 Company Business Overview
11.3.3 Altor BioScience Corporation (USA) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Altor BioScience Corporation (USA) NK Cells Products Offered
11.3.5 Altor BioScience Corporation (USA) Recent Development
11.4 Innate Pharma SA (France)
11.4.1 Innate Pharma SA (France) Company Details
11.4.2 Company Business Overview
11.4.3 Innate Pharma SA (France) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Innate Pharma SA (France) NK Cells Products Offered
11.4.5 Innate Pharma SA (France) Recent Development
11.5 Takeda Pharmaceutical (Japan)
11.5.1 Takeda Pharmaceutical (Japan) Company Details
11.5.2 Company Business Overview
11.5.3 Takeda Pharmaceutical (Japan) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Takeda Pharmaceutical (Japan) NK Cells Products Offered
11.5.5 Takeda Pharmaceutical (Japan) Recent Development
11.6 Sorrento Therapeutics Inc. (USA)
11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
11.6.2 Company Business Overview
11.6.3 Sorrento Therapeutics Inc. (USA) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sorrento Therapeutics Inc. (USA) NK Cells Products Offered
11.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
11.7 NantKwest Inc. (USA)
11.7.1 NantKwest Inc. (USA) Company Details
11.7.2 Company Business Overview
11.7.3 NantKwest Inc. (USA) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.7.4 NantKwest Inc. (USA) NK Cells Products Offered
11.7.5 NantKwest Inc. (USA) Recent Development
11.8 Bristol-Myers Squibb (USA)
11.8.1 Bristol-Myers Squibb (USA) Company Details
11.8.2 Company Business Overview
11.8.3 Bristol-Myers Squibb (USA) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bristol-Myers Squibb (USA) NK Cells Products Offered
11.8.5 Bristol-Myers Squibb (USA) Recent Development
11.9 NKT Therapeutics (USA)
11.9.1 NKT Therapeutics (USA) Company Details
11.9.2 Company Business Overview
11.9.3 NKT Therapeutics (USA) NK Cells Sales, Revenue and Gross Margin (2014-2019)
11.9.4 NKT Therapeutics (USA) NK Cells Products Offered
11.9.5 NKT Therapeutics (USA) Recent Development

12 Future Forecast
12.1 NK Cells Market Forecast by Regions
12.1.1 Global NK Cells Sales Forecast by Regions 2019-2025
12.1.2 Global NK Cells Revenue Forecast by Regions 2019-2025
12.2 NK Cells Market Forecast by Product
12.2.1 Global NK Cells Sales Forecast by Product 2019-2025
12.2.2 Global NK Cells Revenue Forecast by Product 2019-2025
12.3 NK Cells Market Forecast by End User
12.4 North America NK Cells Forecast
12.5 Europe NK Cells Forecast
12.6 Asia Pacific NK Cells Forecast
12.7 Central & South America NK Cells Forecast
12.8 Middle East and Africa NK Cells Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NK Cells Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer